These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1681945)

  • 1. CSF opioids in panic disorder.
    Brady KT; Lydiard RB; Ballenger JC; Shook J; Laraia M; Fossey M
    Biol Psychiatry; 1991 Sep; 30(5):512-4. PubMed ID: 1681945
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered.
    van Wattum PJ; Anderson GM; Chappell PB; Goodman WK; Riddle MA; Leckman JF
    Biol Psychiatry; 1999 Jun; 45(11):1527-8. PubMed ID: 10356639
    [No Abstract]   [Full Text] [Related]  

  • 3. CSF beta-endorphin and dynorphin in bulimia nervosa.
    Brewerton TD; Lydiard RB; Laraia MT; Shook JE; Ballenger JC
    Am J Psychiatry; 1992 Aug; 149(8):1086-90. PubMed ID: 1353317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and CSF HVA levels in panic patients with comorbid social phobia.
    Johnson MR; Lydiard RB; Zealberg JJ; Fossey MD; Ballenger JC
    Biol Psychiatry; 1994 Sep; 36(6):425-7. PubMed ID: 7803603
    [No Abstract]   [Full Text] [Related]  

  • 5. Anxiogenic properties of a computer simulation for panic disorder with agoraphobia.
    Freire RC; De Carvalho MR; Joffily M; Zin WA; Nardi AE
    J Affect Disord; 2010 Sep; 125(1-3):301-6. PubMed ID: 20100626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DSM-III-R state anxiety symptoms in anxiety disorder patients.
    Bruce M; Lader M
    Biol Psychiatry; 1991 Sep; 30(5):519-22. PubMed ID: 1932399
    [No Abstract]   [Full Text] [Related]  

  • 8. Contributing factors associated with agoraphobia.
    Goldberg C
    Psychol Rep; 1993 Feb; 72(1):192-4. PubMed ID: 8451355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of panic disorder.
    Faravelli C; Pallanti S; Biondi F; Paterniti S; Scarpato MA
    Am J Psychiatry; 1992 Jun; 149(6):827-8. PubMed ID: 1590502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic saline infusion induces panic in patients with panic disorder.
    Jensen CF; Peskind ER; Veith RC; Hughes J; Cowley DS; Roy-Byrne P; Raskind MA
    Biol Psychiatry; 1991 Sep; 30(6):628-30. PubMed ID: 1932411
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
    Thornhill JA; Pittman QJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom specificity in patients with panic.
    Lelliott P; Bass C
    Br J Psychiatry; 1990 Oct; 157():593-7. PubMed ID: 2131141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal CSF enlargement in panic disorder: a qualitative CT-scan study.
    Wurthmann C; Bogerts B; Gregor J; Baumann B; Effenberger O; Döhring W
    Psychiatry Res; 1997 Dec; 76(2-3):83-7. PubMed ID: 9522400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavior therapy for panic disorder.
    Freedman S; Adessky R
    Isr J Psychiatry Relat Sci; 2009; 46(4):251-6. PubMed ID: 20635771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity, major depression, and panic disorder comorbidity.
    Andreoli A; Keller SE; Rabaeus M; Zaugg L; Garrone G; Taban C
    Biol Psychiatry; 1992 May; 31(9):896-908. PubMed ID: 1637930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia.
    Lesem MD; Berrettini WH; Kaye WH; Jimerson DC
    Biol Psychiatry; 1991 Feb; 29(3):244-52. PubMed ID: 1673064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alexithymia and anxiety sensitivity in panic disorder and obsessive-compulsive disorder.
    Zeitlin SB; McNally RJ
    Am J Psychiatry; 1993 Apr; 150(4):658-60. PubMed ID: 8031330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.
    Kaye WH; Berrettini WH; Gwirtsman HE; Chretien M; Gold PW; George DT; Jimerson DC; Ebert MH
    Life Sci; 1987 Nov; 41(18):2147-55. PubMed ID: 2823041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety sensitivity distinguishes panic disorder from generalized anxiety disorder.
    McNally RJ
    J Nerv Ment Dis; 1992 Nov; 180(11):737-8. PubMed ID: 1431831
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patients.
    Zhang AZ; Zhou GZ; Xi GF; Gu NF; Xia ZY; Yao JL; Chang JK; Webber R; Potkin S
    Neuropeptides; 1985 Feb; 5(4-6):553-6. PubMed ID: 2860611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.